In the ever-evolving landscape of scientific research, access to reliable, high-quality samples is paramount. Researchers and scientists continually seek for the gold standard to de-risk their research programs and increase the odds of success. dsm-firmenich has therefore introduced a program to support academics and progress CBD-based pre-clinical and early clinical research. As a purpose-led partner committed to excellence, we offer the opportunity to request CBD GMP API or formulated CBD drug intermediate samples for not-for-profit research purposes.
dsm-firmenich supports solid science conducted for the benefit of patients and awards samples at its discretion, reserving the right to decline a request, if not compliant with dsm-firmenich’s ethical standards. For questions, please contact Zdravka Misic, Innovation Project Manager, at zdravka.misic@dsm-firmenich.com.
Get in touch with a dsm-firmenich Pharma specialist or find contacts around the world to suit your needs.
At dsm-firmenich, we love to connect with other humans.
Follow us on any of the channels below.